Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II (PROTECTII)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02003469|
Recruitment Status : Completed
First Posted : December 6, 2013
Last Update Posted : February 23, 2017
University of Michigan
Information provided by (Responsible Party):
Silas P. Norman, University of Michigan
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||September 2013|
|Actual Study Completion Date :||September 2013|
Marcén R. Cardiovascular risk factors in renal transplantation--current controversies. Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii3-8.
Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis. 2005 Sep;46(3):529-36.